PrEP can reduce the risk of sexually transmitted HIV infection by 99%. Discrimination and distrust are two barriers Black gay ...

HIV stigma, for the first time in five years, is on the decline in the United States, despite knowledge gaps in certain ...

Gilead Science’s twice-yearly shot for treating HIV prevented new infections by 96% among patients in a late-stage trial, ...

An event in Palm Springs will feature experts discussing updates in HIV research, as well as those living with HIV sharing ...

Progress in preventing infections was being made in the country with Europe's second-highest number of HIV cases. Then came ...

The Joint United Nations Programme on HIV/AIDS has raised alarm over the increasing incidence of HIV among young people in ...

Through decades of pioneering work on fighting the spread of infectious diseases such as HIV, South African public health ...

Mpumalanga had the highest HIV prevalence in 2022 at 17.4%, with rural areas most affected. ART coverage increased, but ...

Lenacapavir, a new HIV prevention drug, has proven to dramatically reduce the risk of infection according to data reported ...

A micro planning pioneering programme by the National AIDS Council (NAC) in Mashonaland Central Province, in Zimbabwe is ...

Gilead’s twice-yearly injection for HIV prevention cut infections by 96% in a late-stage trial, the company said Thursday, ...

A drug currently used to treat HIV has also been found to dramatically reduce the risk of infection, significantly more than the primary option available for pre-exposure prophylaxis or PrEP.